SynBiotic SE (DUSE:SBX)
Germany · Delayed Price · Currency is EUR 0.1522
-0.7278 (-82.70%)
At close: Oct 20, 2026
SynBiotic SE Market Cap
SynBiotic SE has a market cap or net worth of €1.13 million as of November 4, 2026. Its market cap has decreased by 93.68% in one year.
Market Cap
1.13M
Enterprise Value
1.22M
Revenue
14.86M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 7, 2021, SynBiotic SE's market cap has decreased from 49.05M to 1.13M, a decrease of -97.70%. That is a compound annual growth rate of -47.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.13M | -94.13% |
| Dec 30, 2025 | 19.24M | -32.82% |
| Dec 30, 2024 | 28.64M | 107.48% |
| Dec 29, 2023 | 13.81M | -64.07% |
| Dec 30, 2022 | 38.43M | -60.60% |
| Dec 30, 2021 | 97.53M | 98.83% |
| Jan 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 65.22B |
| Bayer Aktiengesellschaft | 49.14B |
| Siemens Healthineers AG | 48.31B |
| Fresenius SE & Co. KGaA | 27.36B |
| NanoRepro AG | 19.80M |
| Maternus-Kliniken Aktiengesellschaft | 18.35M |
| Biofrontera AG | 18.23M |
| Geratherm Medical AG | 11.64M |